Biomarker Academy

Discovery Biomarker Academy is a specialized training and research division of Discovery Life Sciences, originally established in 2008. It operates as a peer-to-peer pathologist training program focused on the standardized interpretation and scoring of clinical biomarkers, such as PD-L1 and HER2. The Academy has trained over 6,000 pathologists worldwide, facilitating the global harmonization of biomarker assays for clinical trials and diagnostic adoption. By providing expert-led education and standardized protocols, the Academy supports pharmaceutical and biotechnology companies in de-risking clinical trials and accelerating the path to regulatory approval for precision medicines.